Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 262

1.

Tumor-derived hepatocyte growth factor is associated with poor prognosis of patients with glioma and influences the chemosensitivity of glioma cell line to cisplatin in vitro.

Guo YF, Wang XB, Tian XY, Li Y, Li B, Huang Q, Zhang M, Li Z.

World J Surg Oncol. 2012 Jun 28;10:128.

PMID:
22741575
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Elevated expression of macrophage migration inhibitory factor correlates with tumor recurrence and poor prognosis of patients with gliomas.

Wang XB, Tian XY, Li Y, Li B, Li Z.

J Neurooncol. 2012 Jan;106(1):43-51. doi: 10.1007/s11060-011-0640-3. Epub 2011 Jul 3.

PMID:
21725855
[PubMed - indexed for MEDLINE]
3.

Oncogenic role of SOX9 expression in human malignant glioma.

Wang L, He S, Yuan J, Mao X, Cao Y, Zong J, Tu Y, Zhang Y.

Med Oncol. 2012 Dec;29(5):3484-90. doi: 10.1007/s12032-012-0267-z. Epub 2012 Jun 20.

PMID:
22714060
[PubMed - indexed for MEDLINE]
4.

Up-regulated oncoprotein P28GANK correlates with proliferation and poor prognosis of human glioma.

Yang Y, Zhang C, Li L, Gao Y, Luo X, Zhang Y, Liu W, Fei Z.

World J Surg Oncol. 2012 Aug 22;10:169. doi: 10.1186/1477-7819-10-169.

PMID:
22913315
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.

Hagemann C, Fuchs S, Monoranu CM, Herrmann P, Smith J, Hohmann T, Grabiec U, Kessler AF, Dehghani F, Löhr M, Ernestus RI, Vince GH, Stein U.

Neuro Oncol. 2013 Dec;15(12):1696-709. doi: 10.1093/neuonc/not136. Epub 2013 Nov 11.

PMID:
24220141
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

REV3L confers chemoresistance to cisplatin in human gliomas: the potential of its RNAi for synergistic therapy.

Wang H, Zhang SY, Wang S, Lu J, Wu W, Weng L, Chen D, Zhang Y, Lu Z, Yang J, Chen Y, Zhang X, Chen X, Xi C, Lu D, Zhao S.

Neuro Oncol. 2009 Dec;11(6):790-802. doi: 10.1215/15228517-2009-015. Epub .

PMID:
19289490
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

PHA665752, a small-molecule inhibitor of c-Met, inhibits hepatocyte growth factor-stimulated migration and proliferation of c-Met-positive neuroblastoma cells.

Crosswell HE, Dasgupta A, Alvarado CS, Watt T, Christensen JG, De P, Durden DL, Findley HW.

BMC Cancer. 2009 Nov 25;9:411. doi: 10.1186/1471-2407-9-411.

PMID:
19939254
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.

Yamamoto S, Wakimoto H, Aoyagi M, Hirakawa K, Hamada H.

Jpn J Cancer Res. 1997 Jun;88(6):564-77.

PMID:
9263534
[PubMed - indexed for MEDLINE]
9.

The expression of cytoglobin as a prognostic factor in gliomas: a retrospective analysis of 88 patients.

Xu HW, Huang YJ, Xie ZY, Lin L, Guo YC, Zhuang ZR, Lin XP, Zhou W, Li M, Huang HH, Wei XL, Man K, Zhang GJ.

BMC Cancer. 2013 May 20;13:247. doi: 10.1186/1471-2407-13-247.

PMID:
23688241
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Hepatocyte growth factor is associated with poor prognosis of malignant gliomas and is a predictor for recurrence of meningioma.

Arrieta O, Garcia E, Guevara P, Garcia-Navarrete R, Ondarza R, Rembao D, Sotelo J.

Cancer. 2002 Jun 15;94(12):3210-8.

PMID:
12115353
[PubMed - indexed for MEDLINE]
Free Article
11.

Altered expression of E-cadherin by hepatocyte growth factor and effect on the prognosis of nasopharyngeal carcinoma.

Xie LQ, Bian LJ, Li Z, Li Y, Li ZX, Li B.

Ann Surg Oncol. 2010 Jul;17(7):1927-36. doi: 10.1245/s10434-010-0922-6. Epub 2010 Feb 4.

PMID:
20131016
[PubMed - indexed for MEDLINE]
12.

Overexpression of CCL20 and its receptor CCR6 predicts poor clinical prognosis in human gliomas.

Wang L, Qin H, Li L, Zhang Y, Tu Y, Feng F, Ji P, Zhang J, Li G, Zhao Z, Gao G.

Med Oncol. 2012 Dec;29(5):3491-7. doi: 10.1007/s12032-012-0314-9. Epub 2012 Aug 28.

PMID:
22926920
[PubMed - indexed for MEDLINE]
13.

Prognostic significance of kappaB-Ras1 expression in gliomas.

Lin H, Wang Y, Zhang X, Liu B, Zhang W, Cheng J.

Med Oncol. 2012 Jun;29(2):1272-9. doi: 10.1007/s12032-011-9835-x. Epub 2011 Feb 8.

PMID:
21302000
[PubMed - indexed for MEDLINE]
14.

Oncogenic reg IV is a novel prognostic marker for glioma patient survival.

Wang Q, Deng J, Yuan J, Wang L, Zhao Z, He S, Zhang Y, Tu Y.

Diagn Pathol. 2012 Jun 19;7:69. doi: 10.1186/1746-1596-7-69.

PMID:
22713481
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

The positive correlation between DJ-1 and β-catenin expression shows prognostic value for patients with glioma.

Wang C, Fang M, Zhang M, Li W, Guan H, Sun Y, Xie S, Zhong X.

Neuropathology. 2013 Dec;33(6):628-36. doi: 10.1111/neup.12041. Epub 2013 May 28.

PMID:
23714193
[PubMed - indexed for MEDLINE]
16.

Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.

Homma J, Yamanaka R, Yajima N, Tsuchiya N, Genkai N, Sano M, Tanaka R.

Oncol Rep. 2006 Mar;15(3):595-601.

PMID:
16465418
[PubMed - indexed for MEDLINE]
17.

Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.

Zagzag D, Blanco C, Friedlander DR, Miller DC, Newcomb EW.

Hum Pathol. 2003 Jan;34(1):48-53.

PMID:
12605366
[PubMed - indexed for MEDLINE]
18.

Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.

Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J.

Cancer Res. 2010 Apr 1;70(7):2932-41. doi: 10.1158/0008-5472.CAN-09-3570. Epub 2010 Mar 16.

PMID:
20233866
[PubMed - indexed for MEDLINE]
Free PMC Article
19.
20.

ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.

Xiong J, Zhou L, Yang M, Lim Y, Zhu YH, Fu DL, Li ZW, Zhong JH, Xiao ZC, Zhou XF.

Neuro Oncol. 2013 Aug;15(8):990-1007. doi: 10.1093/neuonc/not039. Epub 2013 Apr 10.

PMID:
23576602
[PubMed - indexed for MEDLINE]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk